The Ohio State University Wexner Medical Center and College of Medicine is a test site for a multicenter, 30,000-person clinical trial testing an experimental COVID-19 vaccine that was co-developed by the University of Oxford and AstraZeneca, a biopharmaceutical company. Open to the public, the study seeks a mix of health care workers and those at high risk of exposure such as teachers, first responders, college students, factory workers and restaurant employees. Ohio State researchers will recruit 500 adult volunteers for the randomized, double-blind and placebo-controlled trial.
|